Involvement of HB-EGF and EGF receptor transactivation in TGF-β-mediated fibronectin expression in mesangial cells

Kidney International

Volumn 62, Issue 3, 2002, Pages 799-808

  Uchiyama Tanaka, Yoko ^a,b   Matsubara, Hiroaki ^a,b   Mori, Yasukiyo ^a,b   Kosaki, Atsushi ^a,b   Kishimoto, Noriko ^a,b   Amano, Katsuya ^a,b   Higashiyama, Shigeki ^a,b   Iwasaka, Toshiji ^a,b  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cell signaling; Extracellular matrix; Glomerular mesangial cells; Glomerular sclerosis; Heparin binding EGF like growth factor; Transcriptional regulation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALKALINE PHOSPHATASE; BATIMASTAT; CALPHOSTIN C; CANCER GROWTH FACTOR; CYCLOHEXIMIDE; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FIBRONECTIN; HEPARIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C INHIBITOR; PROTEIN INHIBITOR; PROTEIN KINASE C INHIBITOR; SMAD2 PROTEIN; STAUROSPORINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHIMERA; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INACTIVATION; GENETIC STABILITY; GENETIC TRANSFECTION; KIDNEY CELL; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TRANSACTIVATION;

EID: 0036423702     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00537.x     Document Type: Article

References (41)

1. Kitamura M, Suto TS: TGF-β and glomerulonephritis: Anti-inflammatory versus prosclerotic actions. Nephrol Dial Transplant 12:669-679, 1997
2. Bruijn JA, Roos A, De Geus B, De Heer E: Transforming growth factor-β and the glomerular extracellular matrix in renal pathology. J Lab Clin Med 123:34-47, 1994
3. Robert H, Weiss R, Ar R: TGF-β- and angiotensin II-induced mesangial matrix protein secretion is mediated by protein kinase C. Nephrol Dial Transplant 13:2804-2813, 1998
4. Hayashida T, Poncelet AC, Hubchak SC, Schnaper HW: TGF-β1 activates MAP kinase in human mesangial cells: A possible role in collagen expression. Kidney Int 56:1710-1720, 1999
5. Inagaki M, Moustakas A, Lin HY, et al: Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA. Proc Natl Acad Sci USA 90:5359-5363, 1993
6. Schiffer M, Gersdorff G, Bitzer M, et al: Smad proteins and transforming growth factor-signaling. Kidney Int 58(Suppl 77): S45-S52, 2000
7. Helden CH, Miyazono K, Ten Dijike P: TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471, 1997
8. Mulder KM, Morris SL: Activation of p21ras by transforming growth factor beta in epithelial cells. J Biol Chem 267:50295031, 1992
9. Yan Z, Winawer S, Friedman E: Two different signal transduction pathways can be activated by transforming growth factor-β1 in epithelial cells. J Biol Chem 269:13231-13237, 1994
10. Cai H, Erhardt P, Troppmair J, et al: Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduction. Mol Cell Biol 13:7645-7651, 1993
11. Halstead J, Kemp K, Ignotz RA: Evidence for involvement of phospholipase C and protein kinase C in transforming growth factor-β signaling. J Biol Chem 270:13600-13603, 1995
12. Kucich U, Rosenbloom JC, Shen G, et al: TGF-β stimulation of fibronectin transcription in cultured human lung fibroblasts requires active geranylgeranyl transferase I, phosphatidylcholinespecific phospholipase C, protein kinase C-δ, and p38, but not erkl/erk2. Arch Biochem Biophys 374:313-324, 2000
13. Pranzel N, Zwick E, Daub H, et al: EGF receptor transactivation by G-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402:23-30, 1999
14. Eguchi S, Dempsey PJ, Frank GD, et al: Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloproteinase-dependent EGF receptor activation is required for activation of ERK and p38MAPK but not for JNK. J Biol Chem 276: 7957-7962, 2001
15. Fujiyama S, Matsubara H, Nozawa Y, et al: Angiotensin AT1 and AT2 receptor differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ Res 88:22-29, 2001
16. Kalmes A, Vesti BR, Daum G, et al: Hepafin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by hepafin-binding EGF-like growth factor. Circ Res 87:92-98, 2000
17. Raab G, Klagsbrum M: Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1333:F179-F199, 1997
18. Harper PA, Robinson JM, Hoover RL, et al: Improved methods for culturing rat glomerular cells. Kidney Int 26:875-880, 1984
19. Kijima K, Matsubara H, Komuro I, et al: Mechanical stretch induces enhanced expression of angiotensin II receptors in neonatal rat cardiac myocytes. Circ Res 79:887-897, 1996
20. Suzuki J, Matsubara H, Inada M: Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 73:439-447, 1993
21. Tokumura S, Higashiyama S, Endo T, et al: Ectodomain shedding epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J Cell Biol 151:209-220, 2000
22. 2+/calmodulin-dependent transactivation of epidermal growth factor receptor. Circ Res 82:1338-1348, 1998
23. Moriguchi Y, Matsubara H, Mori Y, et al: Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-β synthesis via transcriptional and posttranscriptional mechanism. Circ Res 84:1073-1074, 1999
24. Murasawa S, Mori Y, Matsubara H, et al: Role of calciumsensitive tyrosine kinase PYK2/CAKβ/RAFTK in angiotensin II-induced Ras/ERK signaling. Hypertension 32:668-675, 1998
25. Murasawa S, Matsubara H, Mori Y, et al: Angiotensin II initiates tyrosine kinase Pyk2-dependent signalings leading to activation of Rac1-mediated c-Jun NH2-terminal kinase. J Biol Chem 275: 26856-26863, 2000
26. Kobayashi E, Nakano H, Morimoto M, et al: Calphostin C (UCN1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 159: 548-553, 1989
27. 3H]-staurosporine on various protein kinases. Biochem Biophys Res Commun 171:189-195, 1990
28. Schutzes S, Pottoff K, Machleidt T, et al: TNF activates NF-kappa-B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765-776, 1992
29. Exton JH: Phosphatidylcholine breakdown and signal transduction. Biochim Biophys Acta 1212:26-42, 1994
30. Uchiyama Y, Matsubara H, Nozawa Y, et al: Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells. Kidney Int 60:2153-2163, 2001
31. Harris VK, Coticchia CG, Kagan BE, et al: Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 signal transduction pathways. J Biol Chem 275:1080210811, 2000
32. Higashiyama S, Abraham JA, Klagsbrun M: Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: Dependence on interactions with cell surface heparan sulfate. J Cell Biol 122:933-940, 1993
33. Wojtowicz-Praga SM, Dickson RB, Hawkins M J: Matrix metalloproteinase inhibitors. Invest New Drugs 15:61-75, 1997
34. Collier IE, Wilhelm SM, Eisen AZ, et al.: H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J Biol Chem 263:6579-6587, 1998
35. Turck J, Pollock A, Lovett DH: Gelatinase A is a glomerular mesangial cell growth and differentiation factor. Kidney Int 51: 1397-1400, 1997
36. Hocevar BA, Brown TL, Howe PH: TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 18:1345-1356, 1999
37. Nagao M, Yamauchi J, Kaziro Y, Itola H: Involvement of protein kinase C and Src family tyrosine kinase in Gq/ll-induced activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. J Biol Chem 273:22892-22898, 1998
38. Eguchi S, Numaguchi K, Iwasaki H, et al: Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273:8890-8896, 1998
39. Hayashida T, Poncelet AC, Hubchak S, Schnaper HW: TGF-β activates MAP kinase in human mesangial cells; A possible role in collagen expression. Kidney Int 56:1710-1720, 1999
40. Keski-OJ, Rabhow R, Sawdey M, et al: Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin and type I procollagen by transforming growth factor-β. J Biol Chem 263: 3111-3115, 1988
41. Patel RS, Odermatt E, Schwarzbauer JE, Hynes RO: Organization of the fibronectin gene provides evidence for exon shuffling during evolution. EMBO J 6:2565-2572, 1987